Search

Your search keyword '"Altamirano-Bustamante, Myriam M."' showing total 37 results
Start Over Author "Altamirano-Bustamante, Myriam M." Search Limiters Available in Library Collection
37 results on '"Altamirano-Bustamante, Myriam M."'

3. Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus

Author

Altamirano-Bustamante, Myriam M., Altamirano-Bustamante, Nelly F., Larralde-Laborde, Mateo, Lara-Martínez, Reyna, Leyva-García, Edgar, Garrido-Magaña, Eulalia, Rojas, Gerardo, Jiménez-García, Luis Felipe, Revilla-Monsalve, Cristina, Altamirano, Perla, and Calzada-León, Raúl

Published
2019
Full Text
View/download PDF

4. Revisión de modelos para el análisis de dilemas éticos

Author

Ruíz-Cano, Jennifer, Cantú-Quintanilla, Guillermo R., Ávila-Montiel, Diana, Gamboa-Marrufo, José Domingo, Juárez-Villegas, Luis E., de Hoyos-Bermea, Adalberto, Chávez-López, Adrián, Estrada-Ramírez, Karla P., Merelo-Arias, Carlos A., Altamirano-Bustamante, Myriam M., de la Vega-Morell, Nahum, Peláez-Ballestas, Ingris, Guadarrama-Orozco, Jessica H., Muñoz-Hernández, Onofre, and Garduño-Espinosa, Juan

Published
2015
Full Text
View/download PDF

5. Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field

Author

Villalobos-Alva, Jalil, primary, Ochoa-Toledo, Luis, additional, Villalobos-Alva, Mario Javier, additional, Aliseda, Atocha, additional, Pérez-Escamirosa, Fernando, additional, Altamirano-Bustamante, Nelly F., additional, Ochoa-Fernández, Francine, additional, Zamora-Solís, Ricardo, additional, Villalobos-Alva, Sebastián, additional, Revilla-Monsalve, Cristina, additional, Kemper-Valverde, Nicolás, additional, and Altamirano-Bustamante, Myriam M., additional

Published
2022
Full Text
View/download PDF

6. ¿Qué hacer en casos de niños que requieren tratamientos no autorizados por padres por cuestiones religiosas?

Author

Quintanilla, Guillermo R., primary, Guadarrama-Orozco, Jéssica H., additional, Altamirano- Bustamante, Myriam M., additional, Peláez-Ballestas, Ingrid, additional, Juárez-Villegas, Luis E., additional, de la Vega- Morell, Nahúm, additional, Kelly-García, Javier, additional, de Hoyos-Bermea, Adalberto, additional, Caballero- Velarde, Ma. Cristina, additional, Ávila-Montiel, Diana, additional, Gamboa-Marrufo, José D., additional, Muñoz-Hernández, Onofre, additional, and Garduño-Espinosa, Juan, additional

Published
2022
Full Text
View/download PDF

11. Bibliotherapy as a Non-pharmaceutical Intervention to Enhance Mental Health in Response to the COVID-19 Pandemic: A Mixed-Methods Systematic Review and Bioethical Meta-Analysis

Author

Monroy-Fraustro, Daniela, primary, Maldonado-Castellanos, Isaac, additional, Aboites-Molina, Mónica, additional, Rodríguez, Susana, additional, Sueiras, Perla, additional, Altamirano-Bustamante, Nelly F., additional, de Hoyos-Bermea, Adalberto, additional, and Altamirano-Bustamante, Myriam M., additional

Published
2021
Full Text
View/download PDF

14. Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes

Author

Altamirano-Bustamante, Nelly F., primary, Garrido-Magaña, Eulalia, additional, Morán, Eugenia, additional, Calderón, Aurora, additional, Pasten-Hidalgo, Karina, additional, Castillo-Rodríguez, Rosa Angélica, additional, Rojas, Gerardo, additional, Lara-Martínez, Reyna, additional, Leyva-García, Edgar, additional, Larralde-Laborde, Mateo, additional, Domíguez, Guadalupe, additional, Murata, Chiharu, additional, Margarita-Vazquez, Yolanda, additional, Payro, Rafael, additional, Barbosa, Manuel, additional, Valderrama, Alejandro, additional, Montesinos, Hortencia, additional, Domínguez-Camacho, Alejandra, additional, García-Olmos, Víctor H., additional, Ferrer, Regina, additional, Medina-Bravo, Patricia G., additional, Santoscoy, Fernanda, additional, Revilla-Monsalve, Cristina, additional, Jiménez-García, Luis Felipe, additional, Morán, Julio, additional, Villalobos-Alva, Jalil, additional, Villalobos, Mario Javier, additional, Calzada-León, Raúl, additional, Altamirano, Perla, additional, and Altamirano-Bustamante, Myriam M., additional

Published
2020
Full Text
View/download PDF

15. Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspective

Author

Leyva-García, Edgar, primary, Lara-Martínez, Reyna, additional, Morán-Zanabria, Liborio, additional, Revilla-Monsalve, Cristina, additional, Jiménez-García, Luis Felipe, additional, Oviedo, Norma, additional, Murata, Chiharu, additional, Garrido-Magaña, Eulalia, additional, Altamirano-Bustamante, Nelly F., additional, and Altamirano-Bustamante, Myriam M., additional

Published
2017
Full Text
View/download PDF

16. Today´s medical self and the other: Challenges and evolving solutions for enhanced humanization and quality of care

Author

Sueiras, Perla, primary, Romano-Betech, Victoria, additional, Vergil-Salgado, Alejandro, additional, de Hoyos, Adalberto, additional, Quintana-Vargas, Silvia, additional, Ruddick, William, additional, Castro-Santana, Anaclara, additional, Islas-Andrade, Sergio, additional, Altamirano-Bustamante, Nelly F., additional, and Altamirano-Bustamante, Myriam M., additional

Published
2017
Full Text
View/download PDF

17. Bioética en tiempo real: El Límite de la viabilidad en los recién nacidos

Author

Zamorano Jiménez, Clara Aurora, Chirino-Barceló, Yazmin, Baptista González, Héctor Alfredo, and Altamirano Bustamante, Myriam M

Subjects
Ethics, Recién Nacidos, Prematuros, Ética, Viabilidad Fetal, Fetal viability, Premature newborns
Abstract

Introducción: los avances en la medicina perinatal en sociedades con mayor desarrollo industrial, han generado reducción en las tasas de mortalidad neonatal con una gradual disminución en la edad gestacional con posibilidades de supervivencia. Objetivo: analizar los elementos bioéticos considerados en la toma de decisiones para establecer los límites de viabilidad en el recién nacido. Metodología: se realizó una búsqueda bibliográfica en distintas fuentes y bases de datos electrónicas sobre los aspectos éticos, legal y humanista en relación con el límite de la viabilidad en los recién nacidos. Resultados y conclusiones: se describen dos escenarios clínicos, que son la plataforma para ejemplificar e iniciar el análisis del dilema ético que condiciona el límite de la viabilidad; se discute la zona gris de la neonatología de acuerdo a tasas de sobrevivencia y tasas de mortalidad en distintos países con diferentes características, dividiéndolos en países desarrollados o subdesarrollados. Se realiza el análisis bioético del dilema, en base a las teorías éticas y modelos de discernimiento: teorías utilitarista, deontológica y aretológica. (MÉD UIS.2013;26(3):23-31) IAdvances in perinatal medicine over the past decades have led to reduced rates in neonatal mortality with a gradual decrease in gestational age with chances of survival. The aim of this review is to analyze the elements considered in bioethical decision making to establish the limits of viability in the newborn infant. A literature search was conducted in different sources and electronic databases on different ethics, legal and humanitarian aspects in relation to the limit of neonatal viability. We describe two clinical scenarios, which are the platform to start the analysis of the ethical dilemma that determines the limit of viability. We discuss the "gray zone" of neonatology according to survival and mortality rates in different countries with distinctive characteristics, dividing them into developed and developing countries. Bioethical analysis is performed of the dilemma, based on ethical theories and models of judgment: utilitarian, deontological and aretological theories. (MÉD UIS.2013;26(3):23-31)

Published
2013

18. Diabetes Drug Discovery: hIAPP1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets.

Author

Fernández-Gómez, Isaac, Sablón-Carrazana, Marquiza, Bencomo-Martínez, Alberto, Domínguez, Guadalupe, Lara-Martínez, Reyna, Altamirano-Bustamante, Nelly F., Jiménez-García, Luis Felipe, Pasten-Hidalgo, Karina, Castillo-Rodríguez, Rosa Angélica, Altamirano, Perla, Marrero, Suchitil Rivera, Revilla-Monsalve, Cristina, Valdés-Sosa, Peter, Salamanca-Gómez, Fabio, Garrido-Magaña, Eulalia, Rodríguez-Tanty, Chryslaine, and Altamirano-Bustamante, Myriam M.

Abstract

Human islet amyloid peptide (hIAPP1–37) aggregation is an early step in Diabetes Mellitus. We aimed to evaluate a family of pharmaco-chaperones to act as modulators that provide dynamic interventions and the multi-target capacity (native state, cytotoxic oligomers, protofilaments and fibrils of hIAPP1–37) required to meet the treatment challenges of diabetes. We used a cross-functional approach that combines in silico and in vitro biochemical and biophysical methods to study the hIAPP1–37 aggregation-oligomerization process as to reveal novel potential anti-diabetic drugs. The family of pharmaco-chaperones are modulators of the oligomerization and fibre formation of hIAPP1–37. When they interact with the amino acid in the amyloid-like steric zipper zone, they inhibit and/or delay the aggregation-oligomerization pathway by binding and stabilizing several amyloid structures of hIAPP1–37. Moreover, they can protect cerebellar granule cells (CGC) from the cytotoxicity produced by the hIAPP1–37 oligomers. The modulation of proteostasis by the family of pharmaco-chaperones A–F is a promising potential approach to limit the onset and progression of diabetes and its comorbidities. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

19. Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.

Author

Avila-Vazquez, Maria Fernanda, Altamirano-Bustamante, Nelly F., and Altamirano-Bustamante, Myriam M.

Subjects
AMYLOID, PROTEOMICS, BIOLOGICAL tags, ALZHEIMER'S disease, OLIGOMERS, ENZYME-linked immunosorbent assay
Abstract

Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

20. Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures

Author

Sablón-Carrazana, Marquiza, primary, Fernández, Isaac, additional, Bencomo, Alberto, additional, Lara-Martínez, Reyna, additional, Rivera-Marrero, Suchitil, additional, Domínguez, Guadalupe, additional, Pérez-Perera, Rafaela, additional, Jiménez-García, Luis Felipe, additional, Altamirano-Bustamante, Nelly F., additional, Diaz-Delgado, Massiel, additional, Vedrenne, Fernand, additional, Rivillas-Acevedo, Lina, additional, Pasten-Hidalgo, Karina, additional, Segura-Valdez, María de Lourdes, additional, Islas-Andrade, Sergio, additional, Garrido-Magaña, Eulalia, additional, Perera-Pintado, Alejandro, additional, Prats-Capote, Anaís, additional, Rodríguez-Tanty, Chryslaine, additional, and Altamirano-Bustamante, Myriam M., additional

Published
2015
Full Text
View/download PDF

21. Fe de errores de “Revisión de modelos para el análisis de dilemas éticos”

Author

Ruíz-Cano, Jennifer, primary, Cantú-Quintanilla, Guillermo R., additional, Ávila-Montiel, Diana, additional, Gamboa-Marrufo, José Domingo, additional, Juárez-Villegas, Luis E., additional, de Hoyos-Bermea, Adalberto, additional, Chávez-López, Adrián, additional, Estrada-Ramírez, Karla P., additional, Merelo-Arias, Carlos A., additional, Altamirano-Bustamante, Myriam M., additional, de la Vega-Morell, Nahum, additional, Peláez-Ballestas, Ingris, additional, Guadarrama-Orozco, Jessica H., additional, Muñoz-Hernández, Onofre, additional, and Garduño-Espinosa, Juan, additional

Published
2015
Full Text
View/download PDF

23. Cardiovascular medicine at face value: a qualitative pilot study on clinical axiology

Author

de Hoyos, Adalberto, primary, Nava-Diosdado, Rodrigo, additional, Mendez, Jorge, additional, Ricco, Sergio, additional, Serrano, Ana, additional, Flores Cisneros, Carmen, additional, Macías-Ojeda, Carlos, additional, Cisneros, Héctor, additional, Bialostozky, David, additional, Altamirano-Bustamante, Nelly, additional, and Altamirano-Bustamante, Myriam M, additional

Published
2013
Full Text
View/download PDF

24. Promoting networks between evidence-based medicine and values-based medicine in continuing medical education

Author

Altamirano-Bustamante, Myriam M, primary, Altamirano-Bustamante, Nelly F, additional, Lifshitz, Alberto, additional, Mora-Magaña, Ignacio, additional, de Hoyos, Adalberto, additional, Ávila-Osorio, María Teresa, additional, Quintana-Vargas, Silvia, additional, Aguirre, Jorge A, additional, Méndez, Jorge, additional, Murata, Chiharu, additional, Nava-Diosdado, Rodrigo, additional, Martínez-González, Oscar, additional, Calleja, Elisa, additional, Vargas, Raúl, additional, Mejía-Arangure, Juan Manuel, additional, Cortez-Domínguez, Araceli, additional, Vedrenne-Gutiérrez, Fernand, additional, Sueiras, Perla, additional, Garduño, Juan, additional, Islas-Andrade, Sergio, additional, Salamanca, Fabio, additional, Kumate-Rodríguez, Jesús, additional, and Reyes-Fuentes, Alejandro, additional

Published
2013
Full Text
View/download PDF

25. Reexamining Healthcare Justice in the Light of Empirical Data.

Author

Hoyos, Adalberto, Monteón, Yareni, and Altamirano‐Bustamante, Myriam M.

Subjects
ATTITUDE (Psychology), COMMUNICATIVE competence, COMPARATIVE studies, DECISION making, HUMAN rights, INTERVIEWING, LONGITUDINAL method, RESEARCH methodology, MEDICAL care, MEDICAL ethics, MEDICAL personnel, PATIENT-professional relations, SCIENTIFIC observation, LEGAL status of patients, TRUST, DATA analysis software, PATIENTS' attitudes
Abstract

This article discusses the notion of justice from a capabilities approach. We undertake an empirical analysis of the concepts of justice held by healthcare personnel, gleaned from a qualitative analysis of interviews on the subject of ethical dilemmas in everyday practice. The article states that Justice undoubtedly presents a work in progress, which implicates the link between justice as capability and human dignity. We empirically found a contrast between the views of justice based on the patient's own perceptions and those based on the perceptions of healthcare personnel. We establish the kind of actions, communication skills and justice required to build a stronger relationship between patients and healthcare professionals, which would improve prognosis, treatment efficiency and therapeutic adhesion. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

27. Evaluación del crecimiento: estado nutricional.

Author

Altamirano-Bustamante, Nelly F., Altamirano-Bustamante, Myriam M., Valderrama-Hernández, Alejandro, and Montesinos-Correa, Hortencia

Subjects
*CHILD nutrition, *PREVENTION of childhood obesity, *CHILD development, *MALNUTRITION in children, *BODY weight, *PARAMETERS (Statistics), *PREVENTION
Published
2014
Full Text
View/download PDF

28. La evaluación del crecimiento.

Author

Altamirano-Bustamante, Nelly F., Altamirano-Bustamante, Myriam M., Valderrama-Hernández, Alejandro, and Montesinos-Correa, Hortencia

Published
2014

29. Del proteoma humano a la medicina transfuncional personalizada.

Author

Altamirano Bustamante, Myriam M., Altamirano Bustamante, Nelly F., Espinosa, Juan Garduño, Hernández, Onofre Muñoz, López, Javier Torres, and Bustamante, Eréndira Altamirano

Subjects
*HUMAN genetics, *MEDICAL publishing, *DIGNITY, *VIRTUES, *DIAGNOSIS, *THERAPEUTICS, *PROTEINS
Published
2010

30. Consentimiento informado en grupos vulnerables: participación de niños y adolescentes en protocolos de investigación.

Author

Bustamante, Nelly Altamirano, Bustamante, Eréndira Altamirano, Vargas, Alberto Olaya, de Rubens, Jesús, de la Puente, Silvestre García, and Altamirano Bustamante, Myriam M.

Subjects
INFORMED consent (Medical law), AUTONOMY (Psychology), CHILD psychology, ADOLESCENT psychology, DECISION making in children, PHYSICIAN-patient relations, MEDICAL practice
Published
2010

31. ¿Cómo prepararnos para la deliberación ética en la práctica clínica en pediatría?

Author

Altamirano Bustamante, Nelly F., Aguirre, Alfredo Bobadilla, Bustamante, Eréndira Altamirano, Espinosa, Juan Garduño, Ávila Osorio, María Teresa, Hernández, Onofre Muñoz, Pavon, Rafael García, and Altamirano Bustamante, Myriam M.

Subjects
MEDICAL ethics, DECISION making in children, MEDICAL practice, EVIDENCE-based medicine, BIOETHICS, MEDICAL publishing
Published
2010

34. Towards medicine of excellence in Mexico: the "Código Infarto" protocol, a view from the perspective of translational bioethics.

Author

Borrayo-Sánchez G, Flores-Morales A, Salas-Collado L, and Altamirano-Bustamante MM

Subjects
Evidence-Based Medicine, Fibrinolytic Agents administration & dosage, Humans, Mexico, Myocardial Reperfusion methods, Myocardial Reperfusion statistics & numerical data, Reproducibility of Results, ST Elevation Myocardial Infarction mortality, Stakeholder Participation, Time-to-Treatment, Bioethical Issues, Clinical Protocols, Emergency Service, Hospital ethics, Myocardial Reperfusion ethics, ST Elevation Myocardial Infarction diagnosis, ST Elevation Myocardial Infarction therapy, Translational Research, Biomedical ethics
Abstract

Introduction: Mexico is the country with the highest mortality due to ST-elevation acute myocardial infarction (STEMI), and the IMSS has therefore developed the protocol of care for emergency departments called Código Infarto (Infarction Code). In this article, aspects of translational medicine are discussed with a bioethical and comprehensive perspective., Objective: To analyze the Código Infarto protocol from the perspective of translational bioethics., Method: A problem-centered approach was carried out through reflective equilibrium (or Rawls' method), as well as by applying the integral method for ethical discernment., Results: The protocol of care for emergency services Código Infarto is governed by evidence-based medicine and value-based medicine; it is guided by a principle of integrity that considers six dimensions of quality for the care of patients with STEMI., Conclusion: The protocol overcomes some adverse social determinants that affect STEMI medical care, reduces mortality and global economic disease burden, and develops medicine of excellence with high social reach., (Copyright: © 2019 Permanyer.)

Published
2020
Full Text
View/download PDF

35. Diabetes Drug Discovery: hIAPP 1-37 Polymorphic Amyloid Structures as Novel Therapeutic Targets.

Author

Fernández-Gómez I, Sablón-Carrazana M, Bencomo-Martínez A, Domínguez G, Lara-Martínez R, Altamirano-Bustamante NF, Jiménez-García LF, Pasten-Hidalgo K, Castillo-Rodríguez RA, Altamirano P, Marrero SR, Revilla-Monsalve C, Valdés-Sosa P, Salamanca-Gómez F, Garrido-Magaña E, Rodríguez-Tanty C, and Altamirano-Bustamante MM

Subjects
Animals, Cell Survival drug effects, Cerebellum pathology, Curcumin chemistry, Curcumin therapeutic use, Diabetes Mellitus pathology, Humans, Islet Amyloid Polypeptide toxicity, Islet Amyloid Polypeptide ultrastructure, Kinetics, Mice, Molecular Docking Simulation, Protein Aggregates, Protein Folding, Protein Multimerization, Rats, Wistar, Amyloid chemistry, Diabetes Mellitus drug therapy, Drug Discovery, Islet Amyloid Polypeptide chemistry, Molecular Targeted Therapy
Abstract

Human islet amyloid peptide (hIAPP 1-37 ) aggregation is an early step in Diabetes Mellitus. We aimed to evaluate a family of pharmaco-chaperones to act as modulators that provide dynamic interventions and the multi-target capacity (native state, cytotoxic oligomers, protofilaments and fibrils of hIAPP 1-37 ) required to meet the treatment challenges of diabetes. We used a cross-functional approach that combines in silico and in vitro biochemical and biophysical methods to study the hIAPP 1-37 aggregation-oligomerization process as to reveal novel potential anti-diabetic drugs. The family of pharmaco-chaperones are modulators of the oligomerization and fibre formation of hIAPP 1-37 . When they interact with the amino acid in the amyloid-like steric zipper zone, they inhibit and/or delay the aggregation-oligomerization pathway by binding and stabilizing several amyloid structures of hIAPP 1-37 . Moreover, they can protect cerebellar granule cells (CGC) from the cytotoxicity produced by the hIAPP 1-37 oligomers. The modulation of proteostasis by the family of pharmaco-chaperones A - F is a promising potential approach to limit the onset and progression of diabetes and its comorbidities., Competing Interests: The author declares having filled two patent applications WO2010118706 A2 and WO2014131374 A1.

Published
2018
Full Text
View/download PDF

36. Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.

Author

Avila-Vazquez MF, Altamirano-Bustamante NF, and Altamirano-Bustamante MM

Subjects
Animals, Enzyme-Linked Immunosorbent Assay, Humans, Protein Aggregates, Amyloid metabolism, Biomarkers analysis, Disease, Protein Conformation
Abstract

Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones., Competing Interests: The authors declare no conflict of interest.

Published
2017
Full Text
View/download PDF

37. [Teenager].

Author

Altamirano-Bustamante N and Altamirano-Bustamante MM

Subjects
Adolescent, Adolescent Nutritional Physiological Phenomena, Animals, Bone Density physiology, Calcium metabolism, Calcium, Dietary administration & dosage, Dairy Products, Female, Humans, Male, Milk, Osteoporosis prevention & control, Pregnancy, Pregnancy in Adolescence, Puberty physiology, Vitamin D administration & dosage, Vitamins administration & dosage, Bone Development physiology, Life Style, Minerals metabolism
Abstract

The bone mass peak is the maximum bone quantity to be achieved through bone modeling. About 40% of the total bone mass is achieved at puberty; therefore, adolescence is critical on the skeletal development. This paper is about the transfunctional analysis of nutrition, mineral metabolism, endocrinology and life style in adolescence. Core factors to achieve the maximum potential of bone modeling through puberty and prevent osteoporosis from a pediatric stage are addressed.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results